Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Bros Advisors Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   287,772    

Indirect Shares

   13,789,697      
Direct Value   $59,327,707    

Indirect Value

   $1,262,987,005      
Total Shares   14,077,469      
Total Value   $1,322,314,712      


Genomic Health Inc $18,271 Seagen Inc $35,226,189 Synageva BioPharma Corp $0 Alexion Pharmaceuticals Inc $24,083,248 Genomic Health Inc $18,271 Seagen Inc $35,226,189 Synageva BioPharma Corp $0 Alexion Pharmaceuticals Inc $24,083,248
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2012-06-19 0 2012-06-19 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-11-21 288 2013-06-05 860,515    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2013-05-17 154,001 2013-05-17 326,648    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 0 2013-10-24 40,308    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2014-06-20 1,520 2014-06-20 367,326    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2016-05-11 131,963 2016-05-11 6,198,972    Premium*  
            Kymera Therapeutics, Inc. KYMR 0 2024-03-28 5,995,928    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KYMR Kymera Therapeutics, Inc.   –       •      –    2024-03-28 3 IO $0.00 $0 I/I 0 5,995,928 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2016-05-11 4 A $0.00 $0 I/I 1,670 6,104,562 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2015-07-22 4 A $0.00 $0 I/I 1,392 6,103,727 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2015-06-22 4/A A $0.00 $0 I/I 6,703,606 6,103,031 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2015-06-22 4/A A $0.00 $0 D/D 131,963 66,153 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2015-06-22 4 A $0.00 $0 I/I 6,703,611 6,103,033 0 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2015-06-22 4 A $0.00 $0 D/D 131,965 66,154 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2014-06-20 4 OE $60.45 $1,798,388 I/I 29,750 223,864 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2014-04-23 4 OE $65.10 $3,645,600 I/I 56,000 219,614 0 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2013-10-24 4 B $17.50 $7,000,000 I/I 400,000 40,308 1.5 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2013-07-09 3 IO $0.00 $0 I/I 0 1,980,074 -
GHDX Genomic Health Inc Director   –       •       •   2013-06-05 4 B $35.82 $7,799,540 I/I 217,773 301,215 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-06-04 4 B $36.62 $5,993,193 I/I 163,659 296,480 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-06-03 4 B $36.69 $4,708,433 I/I 128,341 292,922 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-31 4 B $36.75 $1,883,256 I/I 51,242 290,132 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-29 4 B $36.82 $1,730,615 I/I 47,000 289,018 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-28 4 B $36.93 $2,742,933 I/I 74,266 287,997 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-24 4 B $36.93 $2,308,909 I/I 62,517 286,384 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-23 4 B $36.18 $623,799 I/I 16,900 285,026 2.25 -
SGEN Seagen Inc Director   –       •       •   2013-05-17 4 A $0.00 $0 I/I 10,500 326,648 0 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-16 4 B $36.54 $705,426 I/I 19,306 284,659 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-15 4 B $36.41 $1,898,361 I/I 52,133 284,241 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-14 4 B $35.53 $965,899 I/I 27,184 283,112 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-05-13 4 B $34.02 $7,291,166 I/I 213,242 282,523 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2013-02-21 4 B $27.63 $779,359 I/I 28,200 277,189 2.25 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us